Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/182463
Lipid Nanoparticles for the Posterior Eye Segment
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, or Lipid Drug Conjugates) as effective drug carriers for pathologies affecting the posterior ocular segment. Eye anatomy and the most relevant diseases affecting the posterior segment will be summarized. Moreover, preparation methods and different types and subtypes of lipid nanoparticles will also be reviewed. Lipid nanoparticles used as carriers to deliver drugs to the posterior eye segment as well as their administration routes, pharmaceutical forms and ocular distribution will be discussed emphasizing the different targeting strategies most recently employed for ocular drug delivery
Subject (English)
Citation
Citation
BONILLA VIDAL, Lorena, et al. Lipid Nanoparticles for the Posterior Eye Segment. Pharmaceutics. 2022. Vol. 14, num. 1, pags. 90. ISSN 1999-4923. [consulted: 19 of August of 2026]. Available at: https://hdl.handle.net/2445/182463